Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration
Clinical trial NCT03558074 · COMPLETED
Trial details
- NCT number
- NCT03558074
- Sponsor
- Alkahest, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-20
- Primary completion
- 2018-11-29
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.